Cytomegalovirus Diagnostics Market: By Test (Serology, Cell culture, Antigenemia assay, Polymerase Chain Reaction Amplification, Immunohistochemistry, Nucleic acid sequence-based amplification (NASBA), Hybrid capture assay), By Application (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, Others), By End-user (Hospitals, Diagnostic Centers, Others) and Geography  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Cytomegalovirus Diagnostics Market size was valued USD 73.6 million in 2022 and is poised to grow at a significant CAGR of 6.1% from 2023-29. Cytomegalovirus (CMV) infection is the common herpes virus infection having different symptoms which occurs in all ages of people around the world. Cytomegalovirus (CMV) infection is a communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and semen. The infection may spread fast from urine or saliva from people who are infected with CMV having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery. Organ transplant and blood transfusion are the other way for the transmission for the disease. Cytomegalovirus diagnostics market is mainly propelling by the rise in the prevalence of CMV infections, growing awareness about herpes disease, initiatives taken by key market players for the diagnosis of CMV infection are propelling the growth of CMV diagnostics market. Moreover, rise in the support of government, and development of healthcare infrastructure are anticipated to propel growth of CMV diagnostics market. Lack of awareness and price sensitivity are the few factors hampering the growth of CMV diagnostics market.  

The Cytomegalovirus Diagnostics Market Key Developments:
  • In Jun 2017, Abbott received U.S. FDA approval for Real-time CMV molecular test, the only cytomegalovirus test which is available commercially which amplifies two selective regions of CMV genome.
  • In May 2016, Roche received U.S. FDA approval for its cytomegalovirus (CMV) test used in recipients of hematopoietic stem cells transplantation

Global Cytomegalovirus Diagnostics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

N/A

Largest Market

North America

Fastest Growing Market

Asia Pacific

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
LOCATION

Geography

Frequently Asked Questions

Cytomegalovirus Diagnostics Market size was valued USD 73.6 million in 2022, growing at a CAGR of 6.1% during the forecast period 2023-29.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary
2. Global Cytomegalovirus Diagnostics Market Introduction
 2.1. Global Cytomegalovirus Diagnostics Market - Taxonomy
 2.2. Global Cytomegalovirus Diagnostics Market -Definitions
  2.2.1. Test Type
 2.2.2. End User
3. Global Cytomegalovirus Diagnostics Market Dynamics
 3.1. Drivers
 3.2. Restraints
 3.3. Opportunities/Unmet Needs of the Market
 3.4. Trends
 3.5. Global Cytomegalovirus Diagnostics Market Dynamic Factors - Impact Analysis
4. Global Cytomegalovirus Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
 4.3. Market Opportunity Analysis
5. Global Cytomegalovirus Diagnostics Market, By Test Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 5.1. Serology
  5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
 5.2. Cell Culture
  5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
 5.3. Antigenemia Assay
  5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Polymerase Chain Reaction Amplification
  5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
 5.5. Immunohistochemistry
  5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
 5.6. Nucleic Acid Sequence-based Amplification (NASBA)
  5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis
 5.7. Hybrid Capture Assay
  5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis
6. Global Cytomegalovirus Diagnostics Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 6.1. Retinitis
  6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
 6.2. Pneumonia
  6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
 6.3. Gastroenteritis
  6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
 6.4. Encephalitis
  6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
 6.5. Others (Mouth Ulcers, Pharyngitis, etc.)
  6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis
7. Global Cytomegalovirus Diagnostics Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 7.1. Hospitals
  7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
 7.2. Diagnostic Centers
  7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
 7.3. Others
  7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
8. Global Cytomegalovirus Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 8.1. North America
  8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
 8.2. Europe
  8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
 8.3. Asia-Pacific
  8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
 8.4. Latin America
  8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
 8.5. Middle East and Africa
  8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
 8.6. Global Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Region, 2023 - 2029
9. North America Cytomegalovirus Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 9.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Serology
  9.1.2. Cell culture
  9.1.3. Antigenemia assay
  9.1.4. Polymerase Chain Reaction Amplification
  9.1.5. Immunohistochemistry
  9.1.6. Nucleic acid sequence-based amplification (NASBA)
  9.1.7. Hybrid capture assay
 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.2.1. Retinitis
  9.2.2. Pneumonia
  9.2.3. Gastrointestinal Ulcers
  9.2.4. Encephalitis
  9.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.3.1. Hospitals
  9.3.2. Diagnostic Centers
  9.3.3. Others
 9.4. Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.4.1. U.S.
  9.4.2. Canada
 9.5. North America Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2023 - 2029
 9.6. North America Cytomegalovirus Diagnostics Market Dynamics - Trends
10. Europe Cytomegalovirus Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 10.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Serology
  10.1.2. Cell culture
  10.1.3. Antigenemia assay
  10.1.4. Polymerase Chain Reaction Amplification
  10.1.5. Immunohistochemistry
  10.1.6. Nucleic acid sequence-based amplification (NASBA)
  10.1.7. Hybrid capture assay
 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.2.1. Retinitis
  10.2.2. Pneumonia
  10.2.3. Gastrointestinal Ulcers
  10.2.4. Encephalitis
  10.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.3.1. Hospitals
  10.3.2. Diagnostic Centers
  10.3.3. Others
 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Germany
  10.4.2. UK
  10.4.3. France
  10.4.4. Spain
  10.4.5. Italy
  10.4.6. Russia
  10.4.7. Poland
  10.4.8. Rest of Europe
 10.5. Europe Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2023 - 2029
 10.6. Europe Cytomegalovirus Diagnostics Market Dynamics - Trends
11. Asia-Pacific Cytomegalovirus Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  11.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Serology
  11.1.2. Cell culture
  11.1.3. Antigenemia assay
  11.1.4. Polymerase Chain Reaction Amplification
  11.1.5. Immunohistochemistry
  11.1.6. Nucleic acid sequence-based amplification (NASBA)
  11.1.7. Hybrid capture assay
 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.2.1. Retinitis
  11.2.2. Pneumonia
  11.2.3. Gastrointestinal Ulcers
  11.2.4. Encephalitis
  11.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.3.1. Hospitals
  11.3.2. Diagnostic Centers
  11.3.3. Others
 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  11.4.1. Japan
  11.4.2. China
  11.4.3. India
  11.4.4. ASEAN
  11.4.5. Australia & New Zealand
  11.4.6. Rest of Asia-Pacific
 11.5. Asia-Pacific Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2023 - 2029
 11.6. Asia-Pacific Cytomegalovirus Diagnostics Market Dynamics - Trends
12. Latin America Cytomegalovirus Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
 12.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Serology
  12.1.2. Cell culture
  12.1.3. Antigenemia assay
  12.1.4. Polymerase Chain Reaction Amplification
  12.1.5. Immunohistochemistry
  12.1.6. Nucleic acid sequence-based amplification (NASBA)
  12.1.7. Hybrid capture assay
 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.2.1. Retinitis
  12.2.2. Pneumonia
  12.2.3. Gastrointestinal Ulcers
  12.2.4. Encephalitis
  12.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.3.1. Hospitals
  12.3.2. Diagnostic Centers
  12.3.3. Others
 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Brazil
  12.4.2. Mexico
  12.4.3. Argentina
  12.4.4. Venezuela
  12.4.5. Rest of Latin America
 12.5. Latin America Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2023 - 2029
 12.6. Latin America Cytomegalovirus Diagnostics Market Dynamics - Trends
13. Middle East and Africa Cytomegalovirus Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023
  • Cell Medical Ltd. (U.K.)
  • Merck & Co. Inc. (U.S.)
  • Chimerix, Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Affymetrix, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd.( Switzerland)
  • Johnson and Johnson Services Inc.,(U.S.)